{"nct_id":"NCT04278144","title":"A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors","status":"TERMINATED","status_verified_date":"2025-09","start_date":"2020-02-24","start_date_type":"ACTUAL","primary_completion_date":"2024-12-10","primary_completion_date_type":"ACTUAL","completion_date":"2025-02-14","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["BOLT"]}